SJOGREN-LARSSON SYNDROME

Clinical trials for SJOGREN-LARSSON SYNDROME explained in plain language.

Never miss a new study

Get alerted when new SJOGREN-LARSSON SYNDROME trials appear

Sign up with your email to follow new studies for SJOGREN-LARSSON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

First drug trial targets root cause of rare genetic disorder

Disease control Ongoing

This early-stage study is testing whether a new oral medication called ADX-629 is safe and can reduce the buildup of harmful chemicals in people with Sjögren-Larsson syndrome (SLS), a rare genetic disorder. Up to 8 participants with SLS will take the drug for 12 weeks. Researcher…

Matched conditions: SJOGREN-LARSSON SYNDROME

Phase: PHASE1, PHASE2 • Sponsor: University of Nebraska • Aim: Disease control

Last updated Mar 06, 2026 15:38 UTC

SJOGREN-LARSSON SYNDROME

Get alerted when new SJOGREN-LARSSON SYNDROME trials appear

First drug trial targets root cause of rare genetic disorder